Insights for Dubai Investments PJSC

Dubai Investments PJSC has released its 2024 ESG Report, highlighting significant strides in sustainability and innovation.

Dubai Investments PJSC has announced an 18% cash dividend following a robust financial year, highlighting its strategic growth and operational excellence.

Dubai Investments' Globalpharma partners with ZIM Labs to introduce cutting-edge oral drug technology in the UAE.

Dubai Investments PJSC releases its 2024 Integrated Report, showcasing robust growth and strategic diversification.

Dubai Investments PJSC has released a clarifying disclosure regarding the proxy process for shareholders attending the General Assembly.

Dubai Investments PJSC showcases a remarkable 21% growth in net profit for 2024, driven by robust real estate and investment performance.

Dubai Investments PJSC, a prominent player in the diversified investment sector, continues to showcase resilience and strategic expansion. This article delves into the company's recent activities and financial performance, drawing insights from past reports.

Dubai Investments PJSC strengthens regional ties with key MOUs.

Dubai Investments PJSC expands its Mirdif Hills project with the launch of Asayel Avenue, setting new standards for luxury urban living in Dubai.

Globalpharma, a subsidiary of Dubai Investments PJSC, announces plans to launch 25 new pharmaceutical products in 2025, marking a significant expansion.